Vanderbilt Heart and Vascular Institute (VHVI) Archive — Page 1 of 9

July 2, 2026

Trial of novel device aiding patients with acute decompensated heart failure

The device has the potential to reduce the length of stay for ADHF patients by measuring their response to diuretic medication in real time using algorithms, allowing the process of removing fluid to be more efficient.

July 1, 2026

Lived experience, elevated care: A nurse’s journey with kidney disease 

At age 30, she was diagnosed with autosomal dominant polycystic kidney disease (ADPKD), a genetically inherited condition. She is the fourth generation in her family to face it. And the first to survive it.   

April 23, 2026

Vanderbilt Health implants novel device to treat aortic regurgitation in high-risk patients

With the addition of the J-Valve device, Vanderbilt Health now offers minimally invasive procedures to implant devices treating every valve disease. The trial is still enrolling new patients, so other high-risk patients with aortic regurgitation could qualify.

March 18, 2026

Vanderbilt Health uses novel robotic device to place central lines in FDA trial  

A Chattanooga patient says she’s feeling great after becoming the first to receive the robotic‑assisted central line in Nashville.

July 21, 2025

Jonesborough nurse’s heart attack-pregnancy journey leads to Vanderbilt Women’s Heart Center

Her care illustrates the multidisciplinary expertise of the Vanderbilt Women’s Heart Center, Cardiac OB/High-Risk Pregnancy Team and maternal-fetal medicine specialists.

Patient Heather Burich with her husband, Alex.
March 4, 2025

‘That’s the most scared I’ve been:’ 23 weeks pregnant with a heart condition.

Heather Burich had just driven to Clarksville after an appointment on Vanderbilt Health’s Nashville campus when she got a call from a doctor she was yet to meet. The news about her echocardiogram results was alarming.